Note: Ingredients listed on restricted chemical lists
General Information
Version
11.1
Revision date
2025-12-08
Product name
Molnupiravir Capsule Formulation
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
86-571-87268110
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H316, H372
Hazard statements
Code
Statements
H316
Causes mild skin irritation
Section 2
SECTION 2: Hazards identification
Emergency Overview Appearance : powder Colour : white to off-white Odour : No data available Causes mild skin irritation. Causes damage to organs through prolonged or repeated exposure. GHS Classification Skin corrosion/irritation Category 3 Specific target organ toxicity - Category 1 repeated exposure
Signal word
Danger
Hazard statements
H316 Causes mild skin irritation. H372 Causes damage to organs through prolonged or repeated
Prevention
Precautionary statements P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P319 Get medical help if you feel unwell. P332 + P317 If skin irritation occurs: Get medical help.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other physicochemical hazards
Not classified based on available information.
Health hazards
Causes mild skin irritation. Causes damage to organs through prolonged or repeated exposure
Environmental hazards
Not classified based on available information
Other hazards which do not result in classification
Dust contact with the eyes can lead to mechanical irritation. May form explosive dust-air mixture during processing, handling or other means.
2.1 Classification of the substance or mixture
Skin corrosion/irritation : Category 3 Specific target organ toxicity - : Category 1 repeated exposure
